glp-1 medication craving management strategies Dietary intake by patients taking and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs Beyond weight loss: Integrating GLP-1
Description
Emotional eating and slowed metabolism represent other pathways
Clinical trials of these medications have included participants with previous gallbladder removal, though specific safety outcomes in this subgroup have not been systematically reported
Prednisone can counteract semaglutide's blood sugar benefits, making weight loss harder to achieve
One key concern is reduced effectiveness
Withhold treatment temporarily until the resolution of AEs and then resume treatment
[DOI] [PubMed] [Google Scholar] 61.von Loeffelholz C., Birkenfeld A.L
